<html><head></head><body><h1>Nystatin Powder</h1><p class="drug-subtitle"><b>Dosage Form:</b> topical powder<br/></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Overview</li>
<li>Side Effects</li>
<li>Dosage</li>
<li>Professional</li>
<li>Pregnancy</li>
<li class="nav-more">
More&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewBox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/body&gt;&lt;/html&gt;
</li>
</ul><ul>
<li>Description</li>
<li>Clinical Pharmacology</li>
<li>Indications and Usage</li>
<li>Contraindications</li>
<li>Precautions</li>
<li>Drug Interactions</li>
<li>Adverse Reactions/Side Effects</li>
<li class="ddc-toggle-hidden">Dosage and Administration</li>
<li class="ddc-toggle-hidden">How Supplied/Storage and Handling</li>
<li class="ddc-toggle-hidden">References</li>
</ul><h2>Nystatin Powder Description</h2><p class="First">Nystatin is a polyene antifungal antibiotic obtained from <span class="Italics">Streptomyces noursei. </span>The molecular formula for nystatin is C<span class="Sub">47</span>H<span class="Sub">75</span>NO<span class="Sub">17</span>. <br/>
The molecular weight of nystatin is 926.1. </p><p><span class="Bold">Structural Formula:</span></p><p><span class="Bold"></span><br/></p><p>Nystatin Topical Powder is for dermatologic use. Nystatin Topical Powder contains 100,000 USP nystatin units per gram dispersed in talc</p><h2>Nystatin Powder - Clinical Pharmacology</h2><h3>Pharmacokinetics</h3><p class="First">Nystatin is not absorbed from intact skin or mucous membrane.<br/></p><h3>Microbiology</h3><p class="First">Nystatin is an antibiotic which is both fungistatic and fungicidal <span class="Italics">in vitro</span> against a wide variety of yeasts and yeast-like fungi, including <span class="Italics">Candida </span><span class="Italics">albicans</span>, <span class="Italics">C</span>. <span class="Italics">parapsilosis</span>, <span class="Italics">C</span>. <span class="Italics">tropicalis</span>, <span class="Italics">C</span>. <span class="Italics">guilliermondi</span>, <span class="Italics">C</span>. <span class="Italics">pseudotropicalis</span>, <span class="Italics">C</span>. <span class="Italics">krusei</span>, <span class="Italics">Torulopsis</span> <span class="Italics">glabrata</span>, <span class="Italics">Tricophyton</span> <span class="Italics">rubrum</span>, <span class="Italics">T</span>.<span class="Italics">mentagrophytes</span>.</p><p>Nystatin acts by binding to sterols in the cell membrane of susceptible species resulting in a change in membrane permeability and the  subsequent leakage of intracellular components. On repeated subculturing with increasing levels of nystatin, <span class="Italics">Candida </span><span class="Italics">albicans</span> does not develop resistance to nystatin. Generally, resistance to nystatin does not develop during therapy. However,   other species of <span class="Italics">Candida</span> (<span class="Italics">C. tropicalis, C. guilliermondi, C. </span><span class="Italics">krusei, and C. stellatoides</span>) become quite resistant on treatment with nystatin and simultaneously become  cross resistant to amphotericin as well. This resistance is lost when the antibiotic is removed.</p><p>Nystatin exhibits no appreciable activity against bacteria, protozoa, or viruses.</p><h2>Indications and Usage for Nystatin Powder</h2><p class="First">Nystatin Topical Powder is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by <span class="Italics">Candida </span><span class="Italics">albicans </span>and other susceptible <span class="Italics">Candida</span> species.</p><p><span class="Bold">Nystatin Topical Powder is not indicated for systemic, oral, intravaginal or ophthalmic use.</span></p><h2>Contraindications</h2><p class="First"> Nystatin Topical Powder is contraindicated in patients with a history of hypersensitivity to <span class="Bold">any</span> of its components.<br/></p><h2>Precautions</h2><h3>General</h3><p class="First"><span class="Bold">Nystatin Topical Powder should not be used for the treatment of systemic, oral, intravaginal or ophthalmic infections.</span><br/></p><p>If irritation or sensitization develops, treatment should be discontinued and appropriate measures taken as indicated. It is recommended that KOH smears, cultures, or other diagnostic methods be used to confirm the diagnosis of cutaneous or mucocutaneous candidiasis and to rule out infection caused by other<br/>
pathogens.<br/></p><h3>INFORMATION FOR THE PATIENT</h3><p class="First">Patients using this medication should receive the following information and instructions:</p><p>1. The patient should be instructed to use this medication as directed (including the replacement of missed doses). This medication is not for any disorder other than that for which it is prescribed.</p><p>2. Even if symptomatic relief occurs within the first few days of treatment, the patient should be advised not to interrupt  or discontinue therapy until the prescribed course of treatment is completed.</p><p>3. If symptoms of irritation develop, the patient should be advised to notify the physician promptly.</p><h3>Laboratory Tests</h3><p class="First"> If there is a lack of therapeutic response, KOH smears, cultures, or other diagnostic methods should be repeated.<br/></p><h3>Carcinogenesis, Mutagenesis, Impairment of Fertility</h3><p class="First">No long-term animal studies have been performed to evaluate the carcinogenic potential of nystatin. No studies have been performed  to determine the mutagenicity of nystatin or its effects on male or female fertility.<br/></p><h3><span class="Bold">Pregnancy<br/>
Teratogenic Effects</span><br/>
<span class="Italics">Category C</span></h3><p class="First">Animal reproduction studies have not been conducted with any nystatin topical preparation. It also is not known whether these preparations can cause fetal harm when used by a pregnant woman or can affect reproductive capacity. Nystatin topical preparations should be prescribed for a pregnant woman only if the potential benefit to the mother outweighs the potential risk to the fetus.<br/></p><h3>Nursing Mothers</h3><p class="First"> It is not known whether nystatin is excreted in human milk. Caution should be exercised when nystatin is prescribed for a nursing woman.<br/></p><h3>Pediatric Use</h3><p class="First"> Safety and effectiveness have been established in the pediatric population from birth to 16 years. (<span class="Bold">See DOSAGE AND ADMINISTRATION</span>).<br/></p><h3>Geriatric Use</h3><p class="First">Clinical studies with nystatin topical powder did not include sufficient numbers of subjects aged 65 years and older to determine whether they respond differently than younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.<br/></p><h2>Adverse Reactions</h2><p class="First">The frequency of adverse events reported in patients using nystatin topical powder is less than 0.1%. The more common events that were reported include allergic reactions, burning, itching, rash, eczema, and pain on application. (<span class="Bold">See </span><span class="Bold">PRECAUTIONS: General</span>)<br/></p><h2>Nystatin Powder Dosage and Administration</h2><p class="First">Very moist lesions are best treated with the topical dusting powder.<br/></p><h3>Adults and Pediatric Patients (Neonates and Older):</h3><p class="First">Apply to candidal lesions two or three times daily until healing is complete. For fungal infection of the feet caused by <span class="Italics">Candida</span> species, the powder should be dusted on the feet, as well as, in all foot wear.<br/></p><h2>How is Nystatin Powder Supplied</h2><p class="First"> Nystatin Topical Powder is supplied as 100,000 units nystatin per gram in plastic squeeze bottles.</p><p>NDC 42543-352-15 for 15 g.</p><p>NDC 42543-352-30 for 30 g.</p><p>NDC 42543-352-60 for 60 g.</p><h2>STORAGE</h2><p class="First">Store at 20º - 25ºC (68º - 77ºF) and excursions permitted to 15º - 30ºC (59º - 86ºF)  [See USP Controlled Room Temperature]. Avoid excessive heat (40ºC/104ºF). Keep tightly closed. <span class="Bold">Keep out of reach of children.</span></p><p><span class="Bold"> </span></p><p>Manufactured for:</p><p>Vensun Pharmaceuticals, Inc.<br/>
790 Township Line Rd.<br/>
Yardley, PA 19067</p><p>Rev 02, May 2018</p><h2>PRINCIPAL DISPLAY PANEL</h2><p class="First"><span class="Bold">NDC</span><span class="Bold">42543-352-15</span><br/>
<span class="Bold">Nystatin Topical Powder, USP<br/>
100,000 USP units per gram<br/></span> <span class="Bold">15 grams<br/>
FOR TOPICAL USE ONLY<br/></span> <span class="Bold">Not for Ophthalmic Use<br/>
Rx Only<br/></span> <span class="Bold">Vensun </span><span class="Bold">Pharmaceuticals, Inc.</span></p><p><span class="Bold"></span></p><p><span class="Bold"><span class="Bold">NDC</span><span class="Bold">42543-352-30</span><br/>
<span class="Bold">Nystatin Topical Powder, USP<br/>
100,000 USP units per gram<br/></span> <span class="Bold">30 grams<br/>
FOR TOPICAL USE ONLY<br/>
Not for Ophthalmic Use<br/>
Rx Only<br/></span> <span class="Bold"> Vensun </span><span class="Bold">Pharmaceuticals, Inc.</span></span></p><p><span class="Bold"><span class="Bold">NDC</span><span class="Bold">42543-352-60</span><br/>
<span class="Bold">Nystatin Topical Powder, USP<br/>
100,000 USP units per gram<br/></span> <span class="Bold">60 grams<br/>
FOR TOPICAL USE ONLY<br/>
Not for Ophthalmic Use<br/>
Rx Only<br/></span> <span class="Bold"> Vensun </span><span class="Bold">Pharmaceuticals, Inc.</span></span></p><h2>More about nystatin topical</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Imprints, Shape &amp; Color Data</li>
<li>Compare Alternatives</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>21 Reviews</li>
<li>Drug class: topical antifungals</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Nystatin Topical &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(Advanced Reading)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
<li>Nystatin Vaginal &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(Advanced Reading)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li>Nystatin (Topical) &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(Professional Patient Advice)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
<li>Nystatin Cream &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(FDA)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
<li>Nystatin Ointment &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;span&gt;(FDA)&lt;/span&gt;&lt;/body&gt;&lt;/html&gt;</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Cutaneous Candidiasis</li>
<li>Paronychia</li>
<li>Vaginal Yeast Infection</li>
</ul><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>